CytomX Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 25,244.0% | 25,244.0% | -34.1% |
| FY2022 | 115.8% | 115.8% | -38.1% |
| FY2023 | 1.2% | 1.2% | -0.3% |
| FY2024 | -6,988.8% | -6,988.8% | 26.4% |
| FY2025 | -17.5% | -17.5% | -11.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 25,244.0% | 25,244.0% | -34.1% |
| FY2022 | 115.8% | 115.8% | -38.1% |
| FY2023 | 1.2% | 1.2% | -0.3% |
| FY2024 | -6,988.8% | -6,988.8% | 26.4% |
| FY2025 | -17.5% | -17.5% | -11.5% |